SB 32: Greater Transparency In Pharmaceutical Costs and Drug Rebate Programs.

SB 32: Greater Transparency In Pharmaceutical Costs and Drug Rebate Programs.

This bill reestablishes the commission to study greater transparency in pharmaceutical costs and drug rebate programs.

New Futures supports SB 32. Click here to read.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote